US Stock MarketDetailed Quotes

BCRX BioCryst Pharmaceuticals

Watchlist
  • 7.640
  • +0.010+0.13%
Close Aug 16 16:00 ET
  • 7.640
  • 0.0000.00%
Post 20:02 ET
1.58BMarket Cap-10465P/E (TTM)

BioCryst Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioCryst Pharmaceuticals Q2 2024 Earnings Date

Currency：USDAug 5, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
98.32M
109.33M
+11.01M
Beat Est.
+19.19%
+32.54%
+11.20%
EPS
-0.18
-0.06
+0.12
Beat Est.
+54.24%
+85.00%
+67.21%
Analyst Rating
Strong Buy

Aug 17, 2024

BioCryst Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 117.675M--
--2024/Q3-- / 113.893M--
Aug 5, 20242024/Q2109.332M / 98.324M--
May 6, 20242024/Q192.761M / 85.505M--
Feb 26, 20242023/Q493.401M / 89.995M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 117.675M--
--2024/Q3-- / 113.893M--
Aug 5, 20242024/Q2109.332M / 98.324M--
May 6, 20242024/Q192.761M / 85.505M--
Feb 26, 20242023/Q493.401M / 89.995M--

Unlock Free Earnings Estimates

BioCryst Pharmaceuticals Earnings Reports

  • BioCryst Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 6 16:09 ET

  • BioCryst Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 7 16:07 ET

  • BioCryst Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 27 16:16 ET

  • BioCryst Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 8, 2023 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 17, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg